Timothy Eugene Sullivan - Chief Financial Officer at Apellis Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Issuer Symbol
APLS on Nasdaq
All Insider Reports
All Insider Reports

Timothy Eugene Sullivan - trading volume in the past year for Apellis Pharmaceuticals, Inc.

Holdings reported by Timothy Eugene Sullivan for Apellis Pharmaceuticals, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 152,041 $3,819,285 $25.12 28 Jan 2026 Direct
Stock Option (Right to Buy) 232,903 $1,599,675 $19.39 21 Oct 2025 Direct Common Stock
Common Stock 60,396 $1,517,153 $25.12 28 Jan 2026 The Timothy E Sullivan Irrevocable Trust of 2023

Transactions reported by Timothy Eugene Sullivan for Apellis Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.